Violet Therapeutics: Funding, Investors & Team (Oct 2026)
Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.
Violet Therapeutics has raised $4.8M across 1 funding round on record, the most recent a Seed of $4.8M announced in May 2026.
That round is in line with the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Violet Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Violet Therapeutics Funding Rounds
Violet Therapeutics Founders and Leadership Team
Contact details for the Violet Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Violet Therapeutics Funding Compared to Other Health Care Startups
Violet Therapeutics' latest round of $4.8M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Violet Therapeutics in Health Care and Cambridge
Companies Similar to Violet Therapeutics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Violet Therapeutics Funding FAQs
What does Violet Therapeutics do?
Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.
How much funding has Violet Therapeutics raised?
Violet Therapeutics has raised $4.8M across 1 round on record. The most recent is a Seed of $4.8M announced in May 2026.
When did Violet Therapeutics last raise funding?
Violet Therapeutics' most recent funding round on record is a Seed of $4.8M, announced in May 2026.
Who founded Violet Therapeutics?
FundedIQ lists Meredith Fisher (Founder) at Violet Therapeutics.
Where is Violet Therapeutics headquartered?
Violet Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Violet Therapeutics have?
Violet Therapeutics is in the 11-50 employee band.
How does Violet Therapeutics' funding compare to other Health Care startups?
Violet Therapeutics' latest round of $4.8M is in line with the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Violet Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Violet Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.